New Key Statistics Module, Z-Score and F-Score
OTCPK:PURE Key Ratios
Market Cap $ M | 10.64 |
Enterprise Value $ M | 13.91 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 5.60 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1.00 |
EPS (TTM) $ | -0.03 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -4.35 |
EV-to-EBITDA | -4.56 |
PEG | -- |
Shares Outstanding M | 111.86 |
Net Margin (%) | -170.66 |
Operating Margin % | -159.50 |
Pre-tax Margin (%) | -170.66 |
Quick Ratio | 1.02 |
Current Ratio | 1.10 |
ROA % (ttm) | -242.79 |
ROE % (ttm) | -- |
ROIC % (ttm) | -2,541.40 |
Dividend Yield % | -- |
Altman Z-Score | -242.32 |
PURE Number of Guru Trades
PURE Volume of Guru Trades
Gurus Latest Trades with OTCPK:PURE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:PURE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
PURE Bioscience Inc Insider Transactions
No Available Data
News about OTCPK:PURE
Total 0- 1